↓ Skip to main content

Distinct outcomes, ABL1 mutation profile, and transcriptome features between p190 and p210 transcripts in adult Philadelphia-positive acute lymphoblastic leukemia in the TKI era

Overview of attention for article published in Experimental Hematology & Oncology, March 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
14 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Distinct outcomes, ABL1 mutation profile, and transcriptome features between p190 and p210 transcripts in adult Philadelphia-positive acute lymphoblastic leukemia in the TKI era
Published in
Experimental Hematology & Oncology, March 2022
DOI 10.1186/s40164-022-00265-2
Pubmed ID
Authors

Ting Shi, Mixue Xie, Li Chen, Wei Yuan, Yungui Wang, Xin Huang, Wanzhuo Xie, Haitao Meng, Yinjun Lou, Wenjuan Yu, Hongyan Tong, Xiujin Ye, Jinyan Huang, Jie Jin, Honghu Zhu

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 21%
Student > Ph. D. Student 1 7%
Student > Bachelor 1 7%
Student > Master 1 7%
Unknown 8 57%
Readers by discipline Count As %
Medicine and Dentistry 4 29%
Biochemistry, Genetics and Molecular Biology 3 21%
Computer Science 1 7%
Unknown 6 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 March 2022.
All research outputs
#15,174,308
of 23,339,727 outputs
Outputs from Experimental Hematology & Oncology
#139
of 310 outputs
Outputs of similar age
#234,473
of 440,414 outputs
Outputs of similar age from Experimental Hematology & Oncology
#10
of 16 outputs
Altmetric has tracked 23,339,727 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 310 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,414 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.